Novo reported 6% top-line growth and a 3% operating profit decline in the third quarter. Management raised full-year guidance to flat sales and operating profit at the midpoint at constant currencies (from a 3% decline at the midpoint). Shares closed 6% higher in Denmark on Nov. 4.
Novo's Wegovy and Wegovy pill are expanding the obesity treatment market with strong efficacy and convenience, and are poised to remain key drugs until US and EU patent expirations begin in 2031-32.
Tresiba's strong profile in the long-acting insulin market hasn't been enough to defend it from US pricing pressure due to competition from Sanofi and Lilly, and biosimilar insulins have weighed on category pricing since 2017.
Metric | NOVO B | SNY | RHHBY |
|---|---|---|---|
Price/Earnings (Normalized) | 10.51 | 12.55 | 20.93 |
Price/Book Value | 5.53 | 1.40 | 9.54 |
Price/Sales | 3.63 | 1.97 | 4.92 |
Price/Cash Flow | 9.55 | 8.41 | 15.40 |
Metric | NOVO B | SNY | RHHBY |
|---|---|---|---|
Quick Ratio | 0.63 | 0.21 | 0.80 |
Current Ratio | 0.84 | 1.12 | 1.23 |
Interest Coverage | — | 9.10 | 13.49 |
Metric | NOVO B | SNY | RHHBY |
|---|---|---|---|
Return on Assets (Normalized) | 20.15% | 8.44% | 15.81% |
Return on Equity (Normalized) | 56.25% | 15.62% | 48.77% |
Return on Invested Capital (Normalized) | 33.34% | 12.02% | 23.90% |
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Eli Lilly and Co LLY | LOCK|n<$f%t? | LOCK|^F | $1T | |||
| Johnson & Johnson JNJ | LOCK|?zcN!Hz | LOCK|H!Q | $675B | |||
| AbbVie Inc ABBV | LOCK|rLw?>wX | LOCK|B% | $521B | |||
| Roche Holding AG ADR RHHBY | LOCK|%fc>gJq | LOCK|#R | $389B | |||
| Merck & Co Inc MRK | LOCK|F^$Z^@ | LOCK|^%@ | $363B | |||
| Novartis AG ADR NVS | LOCK|tg#^!gXp | LOCK|FF# | $304B | |||
| AstraZeneca PLC AZN | LOCK|NK!L$Gvd | LOCK|^!l | $288B | |||
| Amgen Inc AMGN | LOCK|F%^D?XJR | LOCK|&>% | $253B | |||
| Gilead Sciences Inc GILD | LOCK|J?wVpdm | LOCK|V$ | $211B | |||
| Novo Nordisk AS ADR NVO | LOCK|#NfLTc | LOCK|^d | $180B |
United States